Annovis Bio Plans Three Presentations at CTAD Conference

Bitget2026/10/22 12:10

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Annovis Bio will deliver three presentations at the Clinical Trials on Alzheimer's Disease conference in Boston, Nov. 16-19, 2026.
An oral presentation on buntanetap's mechanism of action is scheduled for Nov. 19 at 3:52 p.m. ET.
Posters cover buntanetap's pivotal early Alzheimer's study and AI-based drug evaluation, displayed Nov. 16, 2 p.m., through Nov. 17, 5:30 p.m. ET.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610220800PRIMZONEFULLFEED9850988) on October 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Annovis Bio Plans Three Presentations at CTAD Conference

You may also like

Crypto prices